Renee D. Gala, EVP & Chief Financial Officer at Jazz Pharmaceuticals plc (JAZZ), sold 2,635 shares at $160.00 ($422K) on 2022-12-21, disclosed to the SEC on 2022-12-22.
Open-market sale of $422k JAZZ by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| JAZZ | SELL | 2023-05-19 | $791K | — | Filing → |
| TBPH | SELL | 2018-08-16 | $2.3M | — | Filing → |
| TBPH | SELL | 2018-05-22 | $243K | — | Filing → |